1. Home
  2. HTLM vs CVM Comparison

HTLM vs CVM Comparison

Compare HTLM & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTLM
  • CVM
  • Stock Information
  • Founded
  • HTLM 2014
  • CVM 1983
  • Country
  • HTLM Singapore
  • CVM United States
  • Employees
  • HTLM N/A
  • CVM N/A
  • Industry
  • HTLM
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HTLM
  • CVM Health Care
  • Exchange
  • HTLM NYSE
  • CVM Nasdaq
  • Market Cap
  • HTLM 60.5M
  • CVM 68.9M
  • IPO Year
  • HTLM 2024
  • CVM 1987
  • Fundamental
  • Price
  • HTLM $4.15
  • CVM $0.56
  • Analyst Decision
  • HTLM
  • CVM
  • Analyst Count
  • HTLM 0
  • CVM 0
  • Target Price
  • HTLM N/A
  • CVM N/A
  • AVG Volume (30 Days)
  • HTLM 43.7K
  • CVM 450.5K
  • Earning Date
  • HTLM 11-26-2024
  • CVM 12-19-2024
  • Dividend Yield
  • HTLM N/A
  • CVM N/A
  • EPS Growth
  • HTLM N/A
  • CVM N/A
  • EPS
  • HTLM 0.02
  • CVM N/A
  • Revenue
  • HTLM $5,160,167.00
  • CVM N/A
  • Revenue This Year
  • HTLM N/A
  • CVM N/A
  • Revenue Next Year
  • HTLM N/A
  • CVM $3,412.81
  • P/E Ratio
  • HTLM $239.66
  • CVM N/A
  • Revenue Growth
  • HTLM N/A
  • CVM N/A
  • 52 Week Low
  • HTLM $3.88
  • CVM $0.54
  • 52 Week High
  • HTLM $4.70
  • CVM $3.23
  • Technical
  • Relative Strength Index (RSI)
  • HTLM N/A
  • CVM 16.07
  • Support Level
  • HTLM N/A
  • CVM $0.54
  • Resistance Level
  • HTLM N/A
  • CVM $0.92
  • Average True Range (ATR)
  • HTLM 0.00
  • CVM 0.06
  • MACD
  • HTLM 0.00
  • CVM -0.02
  • Stochastic Oscillator
  • HTLM 0.00
  • CVM 6.56

About HTLM HOMESTOLIFE LTD

Homestolife Ltd is a home furniture retailers that offers and sells customized furniture solutions in Singapore. It has six retail store locations that sell furniture manufactured from China and other Asian countries.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Share on Social Networks: